Breast Cancer
Conditions
Interventions
Gold Standard:Pathological results
Index test:Lymphovascular Invasion
Sponsors
Lishui Central Hospital
Eligibility
Sex/Gender
All
Age
35 Years to 90 Years
Inclusion criteria
Inclusion criteria: (i) Patients with primary invasive breast cancer confirmed by postoperative pathology; (ii) Patients who underwent dual-energy CT two weeks before surgery; (iii) Patients whose postoperative pathological results were used to evaluate the lymphovascular invasion status.
Exclusion criteria
Exclusion criteria: (i) Patients with a history of other tumors; (ii) Patients who received other anti-tumor treatments before surgery, such as neoadjuvant chemotherapy; (iii) patients with multiple or non-massive lesions; (iv) Patients with poor CT imaging quality that cannot be measured (e.g., severe artifacts); and (v) Patients with incomplete clinical pathological data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DECT image quantitative parameters;Accuracy;Sensitivity;Specificity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pathological evaluation index; | — |
Countries
China
Contacts
Public ContactWeiyue Chen
Lishui Central Hospital
Outcome results
None listed